These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8569533)

  • 1. Anti-hepatitis A virus antibody response elicited in mice by different forms of a synthetic VP1 peptide.
    Haro I; Pinto RM; Gonzalez-Dankaart JF; Perez JA; Reig F; Bosch A
    Microbiol Immunol; 1995; 39(7):485-90. PubMed ID: 8569533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid phase synthesis and immunogenicity of a VP3 peptide from hepatitis A virus.
    Pérez JA; González-Dankaart JF; Reig F; Pintó RM; Bosch A; Haro I
    Biomed Pept Proteins Nucleic Acids; 1995; 1(2):93-100. PubMed ID: 9346860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus.
    Pintó RM; González-Dankaart JF; Sánchez G; Guix S; Gómara MJ; García M; Haro I; Bosch A
    FEBS Lett; 1998 Oct; 438(1-2):106-10. PubMed ID: 9821968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection.
    Gómara MJ; Riedemann S; Vega I; Ibarra H; Ercilla G; Haro I
    J Immunol Methods; 2000 Feb; 234(1-2):23-34. PubMed ID: 10669766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to hepatitis A virus capsid proteins after infection.
    Wang CH; Tschen SY; Heinricy U; Weber M; Flehmig B
    J Clin Microbiol; 1996 Mar; 34(3):707-13. PubMed ID: 8904442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Features of antigen-antibody interaction during use of linear synthetic peptides and multipeptide antigen modeling antigenic determinants of hepatitis A virus].
    Kruglov IV; Simonova TV; Perez JA; Haro I
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):31-4. PubMed ID: 19459474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology.
    Gómara MJ; Ercilla G; Alsina MA; Haro I
    J Immunol Methods; 2000 Dec; 246(1-2):13-24. PubMed ID: 11121543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis A virus (HAV) peptide sequences: evidence for a neutralization domain near the amino terminus of VP1 of HAV.
    Lemon SM; Barclay W; Ferguson M; Murphy P; Jing L; Burke K; Wood D; Katrak K; Sangar D; Minor PD
    Virology; 1992 May; 188(1):285-95. PubMed ID: 1314456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The synthetic peptide 62-75 VP3 of the hepatitis A virus induces virus-binding antibodies].
    Kusov IuIu; Kazachkov IuA; Dzagurov GK; Nastashenko TA; Kozhich AT; Gabrielian AE; Chikin LD; Ivanov VT; Balaian MS
    Vopr Virusol; 1991; 36(2):114-7. PubMed ID: 1652865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries.
    Mattioli S; Imberti L; Stellini R; Primi D
    J Virol; 1995 Sep; 69(9):5294-9. PubMed ID: 7543581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of a sequential B-epitope in the VP2 protein of hepatitis A virus.
    Kulik LN; Ivanov VS; Tchikin LD; Ostrovsky AG; Ivanov VT
    FEBS Lett; 1995 Jun; 367(1):85-8. PubMed ID: 7541374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design.
    Haro I; Pérez S; García M; Chan WC; Ercilla G
    FEBS Lett; 2003 Apr; 540(1-3):133-40. PubMed ID: 12681496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4.
    Ijaz MK; Alkarmi TO; el-Mekki AW; Galadari SH; Dar FK; Babiuk LA
    Vaccine; 1995 Mar; 13(4):331-8. PubMed ID: 7793126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modeling antigenic determinants of the hepatitis A virus using synthetic peptides].
    Kulik LN; Ivanov VS; Chikin LD; Berkova NP; Kozhich AT; Gabriélian AE; Ivanova VT
    Bioorg Khim; 1994 Jul; 20(7):709-19. PubMed ID: 7527634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.
    Johnston JM; Harmon SA; Binn LN; Richards OC; Ehrenfeld E; Summers DF
    J Infect Dis; 1988 Jun; 157(6):1203-11. PubMed ID: 2836522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic priming with recombinant hepatitis A virus capsid proteins produced in Escherichia coli.
    Powdrill TF; Johnston JM
    J Virol; 1991 May; 65(5):2686-90. PubMed ID: 1850041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunological determination of HAV and anti-HAV IgA in the feces of patients with acute type-A hepatitis].
    Angarano G; Coppola S; Frappampina V; Monno L; Santantonio T
    Boll Ist Sieroter Milan; 1982; 61(5):383-9. PubMed ID: 6100166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the hepatitis A virion: peptide mapping of the capsid region.
    Wheeler CM; Robertson BH; Van Nest G; Dina D; Bradley DW; Fields HA
    J Virol; 1986 May; 58(2):307-13. PubMed ID: 3009847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain.
    Zimmerman DH; Lloyd JP; Heisey D; Winship MD; Siwek M; Talor E; Sarin PS
    Vaccine; 2001 Sep; 19(32):4750-9. PubMed ID: 11535326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.
    Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV
    Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.